ClinConnect ClinConnect Logo
Search / Trial NCT05853939

Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials

Launched by STANFORD UNIVERSITY · May 2, 2023

Trial Information

Current as of August 21, 2025

Enrolling by invitation

Keywords

Visual Evoked Potentials Tms Neuroplasticity

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and women, ages 18 to 65
  • Must comprehend English well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales
  • Left- or Right-handed
  • No current or history of neurological disorders
  • No seizure disorder or risk of seizures
  • Exclusion Criteria:
  • Those with a contraindication for MRIs (e.g. implanted metal)
  • Any unstable medical condition
  • History of head trauma with loss of consciousness
  • History of seizures
  • Neurological or uncontrolled medical disease
  • Active substance abuse
  • Diagnosis of psychotic or bipolar disorder
  • Currently taking medications that substantially reduce seizure threshold (e.g., bupropion, olanzapine, chlorpromazine, lithium)
  • Currently pregnant or breastfeeding

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Stanford, California, United States

Stanford, California, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported